Reduced combination of genetic variants to predict and stratify alzheimer's disease

The U.S. Defense Health Agency has awarded a $602,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Vlaams Instituut Voor Biotechnologie (VIB), a non-profit research institute in Belgium. The grant, effective September 1, 2024 through August 31, 2027, will fund VIB's research on a "Reduced Combination of Genetic Variants to Predict and Stratify Alzheimer's Disease." This project aims to advance medical solutions for neurodegenerative diseases. VIB has previously participated as a sub-awardee on larger NIH program projects, leveraging its expertise in areas like cancer, neurodegenerative diseases, and plant biotechnology to contribute to innovative biomedical research. The Military Medical Research and Development program supports a range of investigative projects across medical disciplines to improve health outcomes for military personnel, veterans, and the general public.